Innovation for Your Health
 

PROJECTS

BRIDGE 53

Infectious diseases continue to be one of the largest threats to global health. Novel medical approaches for anti-infectives - active against infections caused by bacteria, viruses, fungi and parasites - are urgently needed to meet challenges such as antimicrobial resistances.

Hamburg`s universities and research institutes focus on the exploration of disease mechanisms and new targets in this field. Additionally, industrial partners in Northern Germany are specialized on the technological validation of novel therapeutic approaches and provide a starting point for promising drug development according to industrial standards.

BRIDGE 53 is as a collaboration platform to provide sustained access to expertise and resources from industrial partners to help academics access early stage drug discovery and development capabilities. Our goal: Stimulation for the formation of new companies and development of therapies with much needed patient benefit in the field for infectious diseases. BRIDGE 53 includes research institutions and industry partners in Hamburg to accelerate drug development and knowledge transfer for anti-infectives as well as adjacent research fields. We bring scientists, industry and company building expertise together to efficiently deliver pre-clinical concepts to the marketplace.

The city of Hamburg and its port is Germany`s gateway to the world. Setting sail for new collaboration formats, the name BRIDGE 53 evolved from Hamburg's latitude coordinates (53° 34‘ 31,15“ N) and contributes to its long, prestigious history for local coordination of global perspectives.

News

Earlier this year, the first two BRIDGE 53 projects were launched between the European Molecular Biology Laboratory (EMBL) and Evotec, as well as between the University Medical Center Hamburg-Eppendorf (UKE), the Heinrich Pette Institute (HPI) and Evotec.

As part of the second call, further projects are to be initiated between the partner institutions BNITM, DESY, EMBL, HPI, UKE, University of Hamburg and Evotec. For more information, please visit our BRIDGE 53 website www.bridge53.org

Funding

BRIDGE 53 is part of the project Hygiene, Infections & Health (HIHeal), which aims to establish a cross-cluster network in the fields of hygiene, infections and health along a common value chain between the clusters Gesundheitswirtschaft Hamburg GmbH and Life Science Nord Management GmbH.

For more information about HIHeal, visit our HIHeal website at www.hiheal.de

The project is funded by the European Regional Development Fund (ERDF) and the Free and Hanseatic City of Hamburg.

 

Contact

Dr. Imke Schneemann
Legienstraße 40
24103 Kiel
Tel.: +49 431 - 9089 6858
E-Mail: schneemann(at)lifesciencenord.de
www.bridge53.org

Project Website

Contact

Dr. Imke Schneemann
Project Manager
P +49.431.9089-6858
e-mail

Partner

  • Desitin

Content loading failure